PART 11 ENFORCEMENT IN CLINICAL TRIALS EASED BY FDA

Washington Drug Letter
KEYWORDS FDA / Guidances
A A

The FDA will relax enforcement of 21 CFR Part 11 rules related to computerized systems used in clinical trials, according to a draft guidance issued last week.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $10.00